Dysregulated immunity in SARS-CoV-2 infected pregnant women.

Morgan L ShererJun LeiPatrick CreisherMinyoung JangRamya ReddyKristin VoegtlineSarah OlsonKirsten LittlefieldHan-Sol ParkRebecca L UrsinAbhinaya GanesanTheresa BoyerDiane M BrownSamantha N WalchAnnukka A R AntarYukari C ManabeKimberly Jones-BeattyWilliam Christopher GoldenAndrew J SatinJeanne S SheffieldAndrew S Pekosz Sabra L KleinIrina Burd

Published in: medRxiv : the preprint server for health sciences (2020)

SARS-CoV-2 infection during pregnancy was characterized by placental inflammation and reduced antiviral antibody responses, which may impact the efficacy of COVID-19 therapeutics in pregnancy. The long-term implications of placental inflammation for neonatal health also requires greater consideration.

Keyphrases

sars cov
respiratory syndrome coronavirus
pregnant women
oxidative stress
coronavirus disease
healthcare
public health
pregnancy outcomes
mental health
preterm birth
health information
climate change
social media